Live Breaking News & Updates on Clinical Laboratory Improvements Amendments|Page 4

Stay updated with breaking news from Clinical laboratory improvements amendments. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Thermo Fisher Scientific to Acquire Point-of-Care Molecular Diagnostics Provider Mesa Biotech

Thermo Fisher Scientific Inc. the world leader in serving science, today announced it has entered into a definitive agreement to acquire Mesa Biotech, Inc., a privately held molecular diagnostic company, for approximately $450 million in cash. Under the terms of the agreement, Thermo Fisher will pay up to an additional $100 million in cash upon the completion of certain milestones following the close of the . ....

United States , San Diego , Mark Stevenson , Ingo Chakravarty , Ken Apicerno , Ron Obrien , Unity Lab Services , Drug Administration , Thermo Fisher , Thermo Fisher Life Sciences Solutions Segment , Mesa Biotech Inc , Exchange Commission , Thermo Fisher Scientific Inc , Clinical Laboratory Improvements Amendments , Fisher Scientific , Our Mission , Thermo Fisher Scientific , Mesa Biotech , Accula System , Emergency Use Authorization , Life Sciences Solutions , Thermo Scientific , Applied Biosystems , Contact Information , ஒன்றுபட்டது மாநிலங்களில் , சான் டியாகோ ,

Thermo Fisher Scientific to acquire Mesa Biotech, gaining COVID-19 testing platform

Thermo Fisher Scientific to acquire Mesa Biotech, gaining COVID-19 testing platform
Thermo Fisher Scientific will acquire San Diego molecular diagnostics company Mesa Biotech for approximately $450m in cash, with up to an additional $100m upon completion of certain milestones.
Privately held Mesa Biotech has developed and commercialized a PCR-based rapid point-of-care testing platform available for detecting infectious diseases including SARS-CoV-2, Influenza A and B, respiratory syncytial virus (RSV) and Strep A. Its patented technology expands the availability of high standard nucleic acid PCR amplification to point-of-care diagnostics.
Mesa Biotech s Accula Flu A/Flu B, RSV and Strep A tests have obtained 510(k) clearance and Clinical Laboratory Improvements Amendments (CLIA) waivers from the U.S. Food and Drug Administration (FDA). ....

United States , Thermo Fisher Life Sciences Solution Segment , Clinical Laboratory Improvements Amendments , Drug Administration , Mesa Biotech , Accula System , Emergency Use Authorization , Thermo Fisher , Life Sciences Solution Segment , Markets Amp Regulations , Thermo Fisher Scientific , Covid 19 , ஒன்றுபட்டது மாநிலங்களில் , தெர்மோ மீனவர் வாழ்க்கை அறிவியல் தீர்வு பிரிவு , மருத்துவ ஆய்வகம் மேம்பாடுகள் திருத்தங்கள் , மீசா பயோடெக் , அவசரம் பயன்பாடு அங்கீகாரம் , தெர்மோ மீனவர் , வாழ்க்கை அறிவியல் தீர்வு பிரிவு , சந்தைகள் ஆம்ப் ஒழுங்குமுறைகள் , தெர்மோ மீனவர் அறிவியல் ,

This lab is helping fight the STI testing shortage caused by COVID-19

This lab is helping fight the STI testing shortage caused by COVID-19
Share Article
MicroGenDX is a PCR and NGS lab with its own lab developed test (LDT) and is not impacted by the same shortages that are causing delays in STI testing elsewhere.
MicroGenDX Logo
MicroGenDX has over 11 years’ experience designing, and validating laboratory developed tests and mitigating risk in supply chains so that we are able to run the test you need when you need it.
ORLANDO, Fla. (PRWEB)
December 21, 2020
In an era when shortages abound, having options is invaluable. Worldwide, labs are facing a scarcity of supplies, as those needed to test for diseases such as sexually transmitted infections (STIs) must be diverted to Covid-19 testing. Enter MicroGenDX, a company specializing in qPCR + Next Generation Sequencing (NGS) microbial molecular diagnostics.a company that designs and set up its own tests an ....

United States , Nick Sanford , Centers For Disease , College Of American Pathology , Clinical Laboratory Improvement Amendments , College Of American Pathologists , Lab Developed Test , Clinical Laboratory Improvements Amendments , Next Generation Sequencing , Disease Control , Section Director , American Pathology , Prostate Testing , American Pathologists , Polymerase Chain Reaction , Next Generation , ஒன்றுபட்டது மாநிலங்களில் , நிக் சான்ஃபோர்ட் , மையங்கள் க்கு நோய் , கல்லூரி ஆஃப் அமெரிக்கன் நோயியல் , மருத்துவ ஆய்வகம் முன்னேற்றம் திருத்தங்கள் , கல்லூரி ஆஃப் அமெரிக்கன் நோயியல் நிபுணர்கள் , ஆய்வகம் உருவாக்கப்பட்டது சோதனை , மருத்துவ ஆய்வகம் மேம்பாடுகள் திருத்தங்கள் , அடுத்தது ஜெநரேஶந் வரிசைப்படுத்துதல் , நோய் கட்டுப்பாடு ,